Plasma levels of IL-7 and IL-15 after reduced intensity conditioned allo-SCT and relationship to acute GVHD (Q82740456)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Plasma levels of IL-7 and IL-15 after reduced intensity conditioned allo-SCT and relationship to acute GVHD (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ibrahim Yakoub-Agha

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

S Thiant

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

J Trauet

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

V Coiteux

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

E de Berranger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

J-P Dessaint

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

6 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132028%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1374-1381

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132028%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2010.300

17 January 2020

exact match

0 references

cites work

Graft-vs-host disease after non-myeloablative hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Acute graft-versus-host disease: differing risk with differing graft sources and conditioning intensity

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Reconstitution of the immune system after hematopoietic stem cell transplantation in humans.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Pathophysiology and management of graft-versus-host disease in the era of reduced-intensity conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Interleukin-7 receptor expression: intelligent design

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

IL-15 is required for sustained lymphopenia-driven proliferation and accumulation of CD8 T cells.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Prolonged secretion of IL-15 in patients with severe forms of acute graft-versus-host disease after allogeneic bone marrow transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Kinetics of plasma cytokines after hematopoietic stem cell transplantation from unrelated donors: the ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Association of serum interleukin-7 levels with the development of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Allogeneic stem-cell transplantation with fludarabine and 2-Gy TBI-based conditioning regimen for chronic hematological malignancy: a study of 25 consecutive patients and a literature review.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

A high proportion of donor CD4+ T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versus-host disease in patients undergoing allogeneic stem cell transplantation for hematological malign

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Impact of early NK cell recovery on development of GvHD and CMV reactivation in dose-reduced regimen prior to allogeneic PBSCT.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Immune reconstitution following myeloablative allogeneic hematopoietic stem cell transplantation: the impact of expanding CD28negative CD8+ T cells on relapse.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

The strength of T cell stimulation determines IL-7 responsiveness, secondary expansion, and lineage commitment of primed human CD4+IL-7Rhi T cells.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Homeostatic proliferation of lymphocytes results in augmented memory-like function and accelerated allograft rejection.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021

Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.300

7 January 2021